NSCLC

You have access
Brain Metastases in NSCLC – are TKIs Changing the Treatment Strategy?
WOLFRAM C.M. DEMPKE, KLAUS EDVARDSEN, SHUN LU, NIELS REINMUTH, MARTIN RECK and AKIRA INOUE

Anticancer Research November 2015, 35 (11) 5797-5806;
You have access
Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy
GEORG HOLGERSSON, STEFAN BERGSTRÖM, PER LIV, JONAS NILSSON, PER EDLUND, CARL BLOMBERG, JAN NYMAN, SIGNE FRIESLAND, SIMON EKMAN, THOMAS ASKLUND, ROGER HENRIKSSON and MICHAEL BERGQVIST

Anticancer Research October 2015, 35 (10) 5491-5497;
You have access
Targeted Therapy for NSCLC–A Double-edged Sword?
WOLFRAM C. M. DEMPKE

Anticancer Research May 2015, 35 (5) 2503-2512;
You have access
Regulatory T-Cells and Micrometastasis in Lymph Nodes of Stage I NSCLC
TAKESHI HANAGIRI, MISAKO FUKUMOTO, YUKIKO KOYANAGI, YUKARI FURUTANI and FUMIHIRO TANAKA

Anticancer Research December 2014, 34 (12) 7185-7190;
You have access
Comparison of Two Dose Levels of Stereotactic Radiosurgery for 1-3 Brain Metastases from Non-small Cell Lung Cancer
DIRK RADES, STEFAN HUTTENLOCHER, MARKUS DAHLKE, DAGMAR HORNUNG, OLIVER BLANCK, PHAM VAN THAI, NGO THUY TRANG, MAI TRONG KHOA and STEVEN E. SCHILD

Anticancer Research December 2014, 34 (12) 7309-7313;
You have access
Predictive and Prognostic Significance of Sodium Levels in Patients with NSCLC Treated by Erlotinib
MARTIN SVATON, ONDREJ FIALA, MILOS PESEK, FRANTISEK BRUHA, PETR MUKENSNABL, JAROSLAV RACEK, MAREK MINARIK and ZDENEK BORTLICEK

Anticancer Research December 2014, 34 (12) 7461-7465;
You have access
Phase II Study of Docetaxel-plus-Bevacizumab Combination Therapy in Patients Previously Treated for Advanced Non-squamous Non-small Cell Lung Cancer
FUMIYOSHI OHYANAGI, NORIKO YANAGITANI, KEITA KUDO, YUKO KAWANO, TOSHIO SAKATANI, AZUSA TANIMOTO, HIRONARI NISHIZAWA, ATSUSHI HORIIKE, SACHIKO HAGIWARA, TAKESHI HORAI and MAKOTO NISHIO

Anticancer Research September 2014, 34 (9) 5153-5158;
You have access
The Role of Neuron-specific Enolase (NSE) and Thimidine Kinase (TK) Levels in Prediction of Efficacy of EGFR-TKIs in Patients with Advanced-stage NSCLC
ONDREJ FIALA, MILOS PESEK, JINDRICH FINEK, LUCIE BENESOVA, MAREK MINARIK, ZBYNEK BORTLICEK and ONDREJ TOPOLCAN

Anticancer Research September 2014, 34 (9) 5193-5198;
You have access
Comparison of Two ERCC1 Antibodies as Prognostic and Predictive Biomarkers for Early Non-small Cell Lung Cancer
THOMAS R. MULEY, MARIA SIANIDOU, MICHAEL THOMAS, HELGE BISCHOFF, HENDRIK DIENEMANN, MICHAEL MEISTER, MARC A. SCHNEIDER, PHILIPP A. SCHNABEL and ARNE WARTH

Anticancer Research July 2014, 34 (7) 3707-3713;
You have access
HSPA2 Is Expressed in Human Tumors and Correlates with Clinical Features in Non-small Cell Lung Carcinoma Patients
DOROTA SCIEGLINSKA, AGNIESZKA GOGLER-PIGLOWSKA, DOROTA BUTKIEWICZ, MYKOLA CHEKAN, EWA MALUSECKA, JOLANTA HARASIM, ANNA HABRYKA and ZDZISLAW KRAWCZYK

Anticancer Research June 2014, 34 (6) 2833-2840;

Main menu

User menu

Search

NSCLC

Pages